title: Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
authors.affiliation: Department of Internal Medicine and Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: Wei
authors.initials: W
authors.lastname: Jiang
authors.forename: Alexander
authors.initials: A
authors.lastname: Glassman
authors.forename: Ranga
authors.initials: R
authors.lastname: Krishnan
authors.forename: Christopher M
authors.initials: CM
authors.lastname: O'Connor
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000453:epidemiology / Q000209:etiology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D002986:Clinical Trials as Topic / Q000941:ethics; D003863:Depression / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005544:Forecasting; D006801:Humans; D007258:Informed Consent; D008297:Male; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000209:etiology*; D011110:Polymorphism, Genetic; D012307:Risk Factors; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics; D012720:Severity of Illness Index; D012737:Sex Factors
chemical_list: D000928:Antidepressive Agents; D050486:Serotonin Plasma Membrane Transport Proteins